Our findings indicate that increases in the concentrations of fasting blood glucose and free fatty acids in the blood of an individual with Metabolic syndrome may trigger the binding of NF-κB to the promoter of fetuin-A, and then stimulate the expression of circulating fetuin-A mRNA to further promote the synthesis and secretion of fetuin-A (25). The gene discussed is NFKB1; the disease is metabolic syndrome.